← All indications
Sirolimus
A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
Subtype terms (1)
More specific conditions that are subtypes of Sirolimus in the MeSH hierarchy.
- Everolimus
5 drugs (4 approved, 1 experimental)
Drugs by status
Phase 1 trials (1)